BK210655 - Arthrex Autologous Conditioned Plasma (ACP) Max PRP System
510(k) Number: BK210655
Applicant: Arthrex, Inc.
Device Name: Arthrex Autologous Conditioned Plasma (ACP) Max™ PRP System
Decision Date: 9/22/2022
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.
510(k) Number: BK210655
Applicant: Arthrex, Inc.
Device Name: Arthrex Autologous Conditioned Plasma (ACP) Max™ PRP System
Decision Date: 9/22/2022